FBXO22 has been implicated as a promoter of tumorigenesis in liver cancer [232], lung cancer [233], and breast cancer [192], suggesting that ubiquitylation of p53 by SCFFBXO22 might underlie such a role. Here, FBXO22 is linked to lung cancer.